Melanoma Trial, Recruiting (NCT04986748)

Melanoma Trial, Recruiting NCT04986748 Sponsor: National Cancer Centre, Singapore Condition: Melanoma

Printed from Voxsanity (voxsanity.com.au) — NCT04986748 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Melanoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with sarcoma or melanoma (a type of cancer).
You have at least one tumour that can be safely biopsied (a small sample taken) or surgically removed.
You or your legal representative are able and willing to sign a consent form agreeing to take part.
You are able to follow and take part in all the procedures required by the study.

Who may not be able to join:

There are no specific reasons listed that would prevent someone from joining, as long as all of the above conditions are met (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Valerie Shiwen Yang, BSc, MB BChir, PhD, National Cancer Centre, Singapore

Phone: +65 6436 8088

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04986748

Sponsor: National Cancer Centre, Singapore

Phase: Not Applicable

Status: Recruiting

Condition: Melanoma

Trial contact: +65 6436 8088

More information: https://clinicaltrials.gov/study/NCT04986748

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with sarcoma or melanoma (a type of cancer).
You have at least one tumour that can be safely biopsied (a small sample taken) or surgically removed.
You or your legal representative are able and willing to sign a consent form agreeing to take part.
You are able to follow and take part in all the procedures required by the study.

Who may not be able to join:

There are no specific reasons listed that would prevent someone from joining, as long as all of the above conditions are met (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Cancer Centre, Singapore

Registry

ClinicalTrials.gov

Start date

8 September 2020

Est. completion

31 October 2028

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Percentage of patients with successful model generation for each tumour subtype.; Rates of radiological response from QPOP-directed treatment regimens.; Survival outcomes from QPOP-directed treatment regimens.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov